Our purposeis to investigate the migration behavior of human mesenchymal stem cells (hMSCs) in response to prostate cancer. The human prostate cancer cell line PC-3 (PC-3) were injected into the flank or axillary of Severe combined immunodeficiency (SCID) mice subcutaneously to establish human prostate cancer xenograft models. hMSCs were harvested from donor's ribs of human cadaver renal transplantation and separated by density gradient centrifuge. hMSCs between passages 4 to 6 were labeled with 4,6-Diamidino-2-phenylindole (DAPI). DAPI-labeled hMSCs were injected into the bearing cancer SCID mice by tail vein (five doses ( 
